Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24582486

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Apr
First author
Pignata S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):363-4. doi: 10.1016/S1470-2045(14)70084-1.
    note
    Source null
    related pmid
    24582485
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2014 Apr;11(4):177. doi: 10.1038/nrclinonc.2014.45.
    note
    Source null
    related pmid
    24642674
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2014 Jun;15(7):e249-50. doi: 10.1016/S1470-2045(14)70214-1.
    note
    Source null
    related pmid
    24872105
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2014 Jun;15(7):e249. doi: 10.1016/S1470-2045(14)70197-4.
    note
    Source null
    related pmid
    24872106
    relationship
    Comment in

Authors and identifiers

  1. name
    Pignata S
    type
    Author
  2. name
    Scambia G
    type
    Author
  3. name
    Katsaros D
    type
    Author
  4. name
    Gallo C
    type
    Author
  5. name
    Pujade-Lauraine E
    type
    Author
  6. name
    De Placido S
    type
    Author
  7. name
    Bologna A
    type
    Author
  8. name
    Weber B
    type
    Author
  9. name
    Raspagliesi F
    type
    Author
  10. name
    Panici PB
    type
    Author
  11. name
    Cormio G
    type
    Author
  12. name
    Sorio R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pignata S
    type
    Author
  2. name
    Scambia G
    type
    Author
  3. name
    Katsaros D
    type
    Author
  4. name
    Gallo C
    type
    Author
  5. name
    Pujade-Lauraine E
    type
    Author
  6. name
    De Placido S
    type
    Author
  7. name
    Bologna A
    type
    Author
  8. name
    Weber B
    type
    Author
  9. name
    Raspagliesi F
    type
    Author
  10. name
    Panici PB
    type
    Author
  11. name
    Cormio G
    type
    Author
  12. name
    Sorio R
    type
    Author
bibliography ids
  1. nci-bib-25ec1d0a0b226de9b55791d6
book metadata
content sha256
446780650e4fcd1b490bdd38d5d3c5a9cb46a343b727b923295f3788267845f1
document type
citation
dois
  1. 10.1016/S1470-2045(14)70049-X
electronic publication date
display
2014 Feb 28
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24582486
immutable id
pubmed:24582486@446780650e4fcd1b490bdd38d5d3c5a9cb46a343b727b923295f3788267845f1
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
396-405
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):363-4. doi: 10.1016/S1470-2045(14)70084-1.
    note
    Source null
    related pmid
    24582485
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2014 Apr;11(4):177. doi: 10.1038/nrclinonc.2014.45.
    note
    Source null
    related pmid
    24642674
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2014 Jun;15(7):e249-50. doi: 10.1016/S1470-2045(14)70214-1.
    note
    Source null
    related pmid
    24872105
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2014 Jun;15(7):e249. doi: 10.1016/S1470-2045(14)70197-4.
    note
    Source null
    related pmid
    24872106
    relationship
    Comment in
outcomes validated
false
pmid
24582486
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
46f4ad461e415341cb54fd7643b6fcb8dee746b23e785274319b5f1bd5c26338
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Apr
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24582486/
title
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Preserved source evidence · Not medical advice